期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Revista da Associacao Medica Brasileira LetPub Score 4.8
50 ratings
Rate
Reputation 5.9 Influence 3.4 Speed 7.0 | ||||||||||||||||
期刊簡稱 | REV ASSOC MED BRAS | ||||||||||||||||
ISSN | 0104-4230 | ||||||||||||||||
E-ISSN | 1806-9282 | ||||||||||||||||
h-index | N.A. | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 16.70%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://www.scielo.br/scielo.php/script_sci_serial/pid_0104-4230/lng_pt/nrm_iso | ||||||||||||||||
在線稿件提交 | |||||||||||||||||
開放訪問 | Yes | ||||||||||||||||
出版商 | Elsevier | ||||||||||||||||
主題領域 | Medicine | ||||||||||||||||
出版國/地區 | BRAZIL | ||||||||||||||||
發行頻率 | |||||||||||||||||
創刊年 | 0 | ||||||||||||||||
每年文章數 | 331每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 97.62% | ||||||||||||||||
OA Related Info | APC: No APC waiver:No Other charges: No Keywords: health sciences Useful LinksAims & ScopeAuthor InstructionsEditorial BoardPeer review | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0104-4230%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 12 Weeks | ||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Revista da Associacao Medica Brasileira] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:30:46 評論於 Medical Subject Headings (MeSH) is a metadata system published by the U.S. National Library of Medicine, widely used in medical information retrieval. It is intended for indexing journal articles and books in the life sciences field. The main purpose of MeSH is to provide classification for the vast number of literature in PubMed/MEDLINE(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 10:05:04 評論於 The abstract of a paper helps readers to connect all parts of the paper together, so it is necessary to avoid excessive detailed descriptions(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 23:36:44 評論於 How to reduce the abstract to meet the word limit required by the journal? What parts should be deleted?(0) 讚! | 龙鳞孝礼 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 19:44:46 評論於 What is MeSH?(0) 讚! | 北国博达 |
作者: 忆莲小郎君 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-05 16:01:51 評論於 What happened afterwards?(0) 讚! | 忆莲小郎君 |
作者: 西域艳青 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-03-15 11:32:42 評論於 This magazine is really outrageous. After preliminary confirmation, it has been showing both waiting for the deputy editor's arrangement and waiting for the editor's confirmation. After a month of continuous urging emails, I was told one week later that the editorial board had changed at the beginning of the year, and no decisions could be made before the new editor took office. I replied asking when the new editor would take office, suggesting that the official website should announce the current lack of editor. One week later, I received a rejection letter directly using the name of the previous editor. It's really a waste of time for this crappy magazine(0) 讚! | 西域艳青 |
作者: 風見明哲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-09-07 20:53:46 評論於 How long does it usually take for the first review of submitted articles?(0) 讚! | 風見明哲 |
作者: 归元芷云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-04-10 22:31:39 評論於 On January 20th, it showed ACCEPTED, and in February they asked me for an ORCID code. After sending it over, there was no reply. I also emailed to ask about the release date, but still have not received a response. Feeling very confused(0) 讚! | 归元芷云 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 08:25:06 評論於 In any case, this bearish trend is unlikely to change, so as long as it doesn't fall, we should consider ourselves lucky(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us